Literature DB >> 32467476

A Narrative Review of the Published Literature, Hospital Practices, and Policies Related to External Ventricular Drains in the United States: The External Ventricular Drain Publications, Practices, and Policies (EVDPoP) Study.

Thanyalak Thamjamrassri1, Kornkamon Yuwapattanawong1, Phuriphong Chanthima1, Monica S Vavilala1,2, Abhijit V Lele1,3,2.   

Abstract

External ventricular drain (EVD) placement and management pose risks to neurocritically ill patients. Yet, little is known about EVD management or hospital EVD management practices and policies in US hospitals. A narrative review was conducted to describe EVD-related publications reported in PubMed and Embase between 1953 and 2019, and a survey was used to examine US hospital EVD practices and policies, including adherence to EVD guideline recommendations. Overall, 912 relevant articles were published between 1953 and 2019 (average 21; range, 0 to 102 articles, per year), primarily related to indications for EVD placement (n=275, 30.2%), EVD-associated complications (n=206, 22.6%), and EVD care (n=200, 21.9%). The number of EVD publications increased over time (R2=0.7), and most publications addressed EVD-associated infection (n=296, 73.4%) and EVD insertion (n=195, 45.2%). Survey responses were received from 30 hospitals (37.5% response rate), and reported use of antimicrobial-impregnated catheters in 80% of hospitals, preinsertion antibiotic administration in 70%, collection of cerebrospinal fluid samples for suspicion of ventriculitis in 73.3%, tracking of EVD-associated infection in 86.7%, routine EVD clamping during transport in 66.7%, and monitoring of intracranial pressure during transport in 33.3%. Adherence to hospital policies was high for recommendations related to flushing an EVD and changing cerebrospinal fluid drainage systems (100% [range, 0% to 100%] each), but low for intrahospital transportation (16.7% [0% to 83.3%]), EVD removal (0% [0% to 66.7%]), patient and family education (0% [0% to 100%]), and administration of intraventricular medication (0% [0% to 100%]). In summary, the published literature related to EVD insertion and maintenance, and reported EVD hospital practices and policies, primarily focus on reducing EVD-associated infections. Still, overall adherence of hospital EVD policies to guideline recommendations is modest. To promote a culture of EVD safety, clinicians should focus on reducing all EVD-associated adverse events.
Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2022        PMID: 32467476      PMCID: PMC9014964          DOI: 10.1097/ANA.0000000000000694

Source DB:  PubMed          Journal:  J Neurosurg Anesthesiol        ISSN: 0898-4921            Impact factor:   3.956


  18 in total

Review 1.  Neuromonitoring in the intensive care unit. I. Intracranial pressure and cerebral blood flow monitoring.

Authors:  Anuj Bhatia; Arun Kumar Gupta
Journal:  Intensive Care Med       Date:  2007-05-24       Impact factor: 17.440

2.  Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support.

Authors:  Paul A Harris; Robert Taylor; Robert Thielke; Jonathon Payne; Nathaniel Gonzalez; Jose G Conde
Journal:  J Biomed Inform       Date:  2008-09-30       Impact factor: 6.317

3.  External ventricular drain practice variations: results from a nationwide survey.

Authors:  Griffin R Baum; Kristopher G Hooten; Dennis T Lockney; Kyle M Fargen; Nefize Turan; Gustavo Pradilla; Gregory J A Murad; Robert E Harbaugh; Michael Glantz
Journal:  J Neurosurg       Date:  2017-01-13       Impact factor: 5.115

4.  Guidelines for the management of aneurysmal subarachnoid hemorrhage: a guideline for healthcare professionals from the American Heart Association/american Stroke Association.

Authors:  E Sander Connolly; Alejandro A Rabinstein; J Ricardo Carhuapoma; Colin P Derdeyn; Jacques Dion; Randall T Higashida; Brian L Hoh; Catherine J Kirkness; Andrew M Naidech; Christopher S Ogilvy; Aman B Patel; B Gregory Thompson; Paul Vespa
Journal:  Stroke       Date:  2012-05-03       Impact factor: 7.914

5.  Perioperative Management of Adult Patients With External Ventricular and Lumbar Drains: Guidelines From the Society for Neuroscience in Anesthesiology and Critical Care.

Authors:  Abhijit V Lele; Amie L Hoefnagel; Nina Schloemerkemper; David A Wyler; Nophanan Chaikittisilpa; Monica S Vavilala; Bhiken I Naik; James H Williams; Lakshmikumar Venkat Raghavan; Ines P Koerner
Journal:  J Neurosurg Anesthesiol       Date:  2017-07       Impact factor: 3.956

6.  Trends in Ventriculostomy-Associated Infections and Mortality in Aneurysmal Subarachnoid Hemorrhage: Data From the Nationwide Inpatient Sample.

Authors:  Roy Poblete; Ling Zheng; Ranjita Raghavan; Steven Cen; Arun Amar; Nerses Sanossian; William Mack; May Kim-Tenser
Journal:  World Neurosurg       Date:  2016-12-27       Impact factor: 2.104

Review 7.  External ventricular drain infection: the effect of a strict protocol on infection rates and a review of the literature.

Authors:  D Dasic; S J Hanna; S Bojanic; R S C Kerr
Journal:  Br J Neurosurg       Date:  2006-10       Impact factor: 1.596

8.  Risks of Routinely Clamping External Ventricular Drains for Intrahospital Transport in Neurocritically Ill Cerebrovascular Patients.

Authors:  Nophanan Chaikittisilpa; Abhijit V Lele; Vivian H Lyons; Bala G Nair; Shu-Fang Newman; Patricia A Blissitt; Monica S Vavilala
Journal:  Neurocrit Care       Date:  2017-04       Impact factor: 3.210

9.  Decreasing ventricular infections through the use of a ventriculostomy placement bundle: experience at a single institution.

Authors:  Zeynep Kubilay; Shahram Amini; Loretta Litz Fauerbach; Lennox Archibald; William A Friedman; A Joseph Layon
Journal:  J Neurosurg       Date:  2012-12-21       Impact factor: 5.115

10.  A simple protocol to prevent external ventricular drain infections.

Authors:  Alexander C Flint; Vivek A Rao; Natalie C Renda; Bonnie S Faigeles; Todd E Lasman; William Sheridan
Journal:  Neurosurgery       Date:  2013-06       Impact factor: 4.654

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.